GT Biopharma Inc Ownership
$7.49
11.96%
Nasdaq, Oct 20, 11:03 am EDT.
Market open.
GT Biopharma Inc Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Marzilli (Robert A)
|
2.128m | 118.89% | +1.428m | Jun 30 2026 |
| 2 |
Vanguard Capital Management, LLC
|
376.399k | 21.03% | -75.476k | Jun 30 2026 |
| 3 |
Breen (Michael Martin)
|
295.206k | 16.49% | +51.667k | Jun 30 2026 |
| 4 |
Geode Capital Management, L.L.C.
|
266.788k | 14.90% | -27.671k | Jun 30 2026 |
| 5 |
Vanguard Fiduciary Trust Co
|
225.938k | 12.62% | — | Jun 30 2026 |
|
1
Marzilli (Robert A)
|
118.89%
2.128m
|
|
2
Vanguard Capital Management, LLC
|
21.03%
376.399k
|
|
3
Breen (Michael Martin)
|
16.49%
295.206k
|
|
4
Geode Capital Management, L.L.C.
|
14.90%
266.788k
|
|
5
Vanguard Fiduciary Trust Co
|
12.62%
225.938k
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 183.93% of GT Biopharma Inc, with Marzilli (Robert A) the biggest at 118.89%, followed by Vanguard Capital Management, LLC (21.03%) and Breen (Michael Martin) (16.49%). |
GT Biopharma Inc Short interest
Powered by
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in GT Biopharma Inc has risen over the past 12 months from around 6.9% to 14.4% of the float. More and more market participants are betting on falling prices. That reflects growing skepticism, but also carries upside potential through a possible short squeeze. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
